A dedicated website for this trial has been set up by Inhibikase.
The 201 Clinical Trial For Patients With Untreated Parkinson’s Disease:
Study record:
classic.clinicaltrials.gov/...
Background information:
A Phase 2 trial of Risvodetinib (IkT-1480... - Cure Parkinson's
A Phase 2 trial of Risvodetinib (IkT-148009) by Inhibikase Therapeutics is currently recruiting untreated PwPs
Written by
jeffreyn
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
Not what you're looking for?
You may also like...
A (minor) update by Inhibikase Therapeutics on their Phase 2 trial of Risvodetinib (IkT-148009) for Parkinson's Disease.
in the trial record].\\"...
Inhibikase Therapeutics Announces FDA Clinical Hold on IkT-148009 Programs
https://www.inhibikase.com/news/press-releases/detail/66/inhibikase-therapeutics-announces-fda-clini
Inhibikase IkT-148009 Phase 2: the study record on the Clinical Trials website has had a small, but significant, update.
estimation of the new completion date.
According to the study record, they are seeking 90...
Dr. Milto Werner, Inhibikase
several posts regarding the progress of trials conducted by Inhibikase. Here's one of several...
Phase 2 Mesenchymal Stem Cell Trial in USA
opened Phase 2 clinical trial is evaluating adult stem cells as a potentially disease-modifying...
Related Posts
A Reversing of Parkinson's the GDNF phase 2 trial
The \"UP-study\" phase 2 trial of UDCA Co funded by Cure Parkinson's led by Prof Oliver Bandmann
Neuraly Announces Topline Results from Phase 2 Trial of NLY01 in Parkinson's Disease
Another potential PD therapeutic drug?
Potential disease-modifying therapy enters Phase 2
